Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices

[1]  G. Barton,et al.  Randomised controlled trial , 2016 .

[2]  Ron Borland,et al.  Electronic Nicotine Delivery System , 2015 .

[3]  M. Caruso,et al.  Correction: EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study , 2014, PLoS ONE.

[4]  K. Farsalinos,et al.  Impact of Flavour Variability on Electronic Cigarette Use Experience: An Internet Survey , 2013, International journal of environmental research and public health.

[5]  Hayden McRobbie,et al.  Electronic cigarettes for smoking cessation: a randomised controlled trial , 2013, The Lancet.

[6]  M. Caruso,et al.  EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study , 2013, PloS one.

[7]  K. Farsalinos,et al.  Evaluation of Electronic Cigarette Use (Vaping) Topography and Estimation of Liquid Consumption: Implications for Research Protocol Standards Definition and for Public Health Authorities’ Regulation , 2013, International journal of environmental research and public health.

[8]  Amanda Roberts,et al.  'Vaping' profiles and preferences: an online survey of electronic cigarette users. , 2013, Addiction.

[9]  A. McNeill,et al.  E-Cigarettes: Prevalence and Attitudes in Great Britain , 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[10]  K. Farsalinos,et al.  Evaluating Nicotine Levels Selection and Patterns of Electronic Cigarette Use in a Group of “Vapers” Who Had Achieved Complete Substitution of Smoking , 2013, Substance abuse : research and treatment.

[11]  T. Eissenberg,et al.  Clinical laboratory assessment of the abuse liability of an electronic cigarette. , 2012, Addiction.

[12]  T. Eissenberg,et al.  A Clinical Laboratory Model for Evaluating the Acute Effects of Electronic “Cigarettes”: Nicotine Delivery Profile and Cardiovascular and Subjective Effects , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[13]  H McRobbie,et al.  Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial , 2010, Tobacco Control.

[14]  R. West,et al.  Is the ten-item Questionnaire of Smoking Urges (QSU-brief) more sensitive to abstinence than shorter craving measures? , 2010, Psychopharmacology.

[15]  C. Phillips.  Debunking the claim that abstinence is usually healthier for smokers than switching to a low-risk alternative, and other observations about anti-tobacco-harm-reduction arguments , 2009, Harm reduction journal.

[16]  J. Geddes,et al.  What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.

[17]  Ron Borland,et al.  Functional beliefs about smoking and quitting activity among adult smokers in four countries: findings from the International Tobacco Control Four-Country Survey. , 2008, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[18]  A. Breland,et al.  Clinical laboratory evaluation of potential reduced exposure products for smokers. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[19]  Karine Guillem,et al.  Monoamine Oxidase Inhibition Dramatically Increases the Motivation to Self-Administer Nicotine in Rats , 2005, The Journal of Neuroscience.

[20]  A. Breland,et al.  Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes. , 2005, Addiction.

[21]  J. Etter.  A self-administered questionnaire to measure cigarette withdrawal symptoms: the Cigarette Withdrawal Scale. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[22]  T. Perneger,et al.  A Self-Administered Questionnaire to Measure Dependence on Cigarettes: The Cigarette Dependence Scale , 2003, Neuropsychopharmacology.

[23]  R. West,et al.  A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler , 2000, Psychopharmacology.

[24]  M. Stitzer,et al.  Manipulation of cigarette craving through rapid smoking: efficacy and effects on smoking behavior , 1999, Psychopharmacology.

[25]  N. Benowitz,et al.  Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. , 1998, The Journal of pharmacology and experimental therapeutics.

[26]  J. Henningfield,et al.  Nicotine delivery kinetics and abuse liability. , 1993, Journal of consulting and clinical psychology.

[27]  N. Benowitz,et al.  Determinants of nicotine intake while chewing nicotine polacrilex gum , 1987, Clinical pharmacology and therapeutics.

[28]  S. Shulman.  What about E-cigarettes? , 2015, Pediatric annals.

[29]  Sarah E. Adkison,et al.  Electronic nicotine delivery systems: international tobacco control four-country survey. , 2013, American journal of preventive medicine.

[30]  K. Fagerström.  Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. , 2012, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[31]  N. Benowitz,et al.  Nicotine chemistry, metabolism, kinetics and biomarkers. , 2009, Handbook of experimental pharmacology.